Treatment of age-related neovascular macular degeneration: the patient’s perspective

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1435-702X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Treatment of age-related neovascular macular degeneration: the patient’s perspective ; volume:255 ; number:11 ; day:4 ; month:8 ; year:2017 ; pages:2237-2246 ; date:11.2017
Graefe's archive for clinical and experimental ophthalmology ; 255, Heft 11 (4.8.2017), 2237-2246, 11.2017

Schlagwort
Augenheilkunde
Augenkrankheit

Urheber
Müller, S.
Beteiligte Personen und Organisationen
Ehlken, C.
Bauer-Steinhusen, U.
Lechtenfeld, W.
Hasanbasic, Z.
Agostini, H.
Wilke, T.
SpringerLink (Online service)

DOI
10.1007/s00417-017-3739-1
URN
urn:nbn:de:1111-201712123564
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:23 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Müller, S.
  • Ehlken, C.
  • Bauer-Steinhusen, U.
  • Lechtenfeld, W.
  • Hasanbasic, Z.
  • Agostini, H.
  • Wilke, T.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration

Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration

Near-infrared reflectance imaging of neovascular age-related macular degeneration

Near-infrared reflectance imaging of neovascular age-related macular degeneration

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration

Vision protection therapy for prevention of neovascular age-related macular degeneration

Vision protection therapy for prevention of neovascular age-related macular degeneration

Efficacy and safety of abicipar in neovascular age-related macular degeneration

Efficacy and safety of abicipar in neovascular age-related macular degeneration

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes

Influence of new societal factors on neovascular age-related macular degeneration outcomes

Influence of new societal factors on neovascular age-related macular degeneration outcomes

Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration

Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration

Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era

Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era

Characterization of two-pore channel 2 in neovascular age-related macular degeneration

Characterization of two-pore channel 2 in neovascular age-related macular degeneration

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye

Verbundene Objekte